Disease Overview：Deep Vein Thrombosis（DVT）
Deep Vein Thrombosis (DVT) is a serious vascular condition characterized by the formation of a thrombus within the deep venous system—most commonly in the lower extremities, such as the femoral or popliteal veins. If left untreated, DVT carries significant risks, including pulmonary embolism (PE), post-thrombotic syndrome (PTS), and chronic venous insufficiency. Diagnosis relies on clinical assessment, D-dimer testing, and confirmatory imaging—primarily compression ultrasonography and, when indicated, CT or MR venography. Management encompasses anticoagulation therapy (e.g., direct oral anticoagulants or low-molecular-weight heparin), mechanical prophylaxis, and, in select cases, catheter-directed thrombolysis or inferior vena cava filter placement. Risk factors include prolonged immobility, surgery, malignancy, inherited thrombophilias, and hormonal therapy.
China offers distinct advantages for DVT care: its leading tertiary hospitals—many accredited by JCI or ISO—employ internationally trained hematologists and interventional radiologists with extensive experience in complex thromboembolic disease. Advanced imaging platforms (e.g., 3T MRI, dual-energy CT) and real-time ultrasound-guided interventions ensure precise diagnosis and minimally invasive treatment. Clinical outcomes align with global benchmarks: multicenter studies from Beijing Union Medical College Hospital and Shanghai Ruijin Hospital report >92% thrombus resolution rates in acute DVT managed with combined pharmacologic and endovascular approaches. Crucially, treatment costs in China are typically 40–60% lower than in the US or Western Europe—without compromising safety or efficacy.
As a dedicated medical tourism agency, we facilitate seamless access to these high-standard services for international patients. We coordinate hospital referrals, verify physician credentials, provide itemized, transparent pricing, and deliver end-to-end support—from visa assistance and accommodation to post-discharge follow-up and multilingual care coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Deep Vein Thrombosis (DVT)
Non-Surgical / Conservative Management
*Target Criteria:* Acute proximal DVT (calf or thigh), low bleeding risk, no contraindications to anticoagulation, stable hemodynamics.
- •Direct Oral Anticoagulants (DOACs)
- Apixaban (10 mg BID × 7 days → 5 mg BID): ¥1,450–¥2,100/month ($202–$292)
- •Low-Molecular-Weight Heparin (LMWH)
- •Monitoring & Labs
- Monthly anti-Xa assay (if LMWH used long-term): ¥180 ($25)
- •Compression Therapy
Surgical / Interventional Procedures
*Eligibility Criteria:* Massive iliofemoral DVT with limb threat (<14 days), contraindication to anticoagulation, recurrent PE despite therapeutic anticoagulation, or failed medical therapy.
- •Catheter-Directed Thrombolysis (CDT)
- •Pharmacomechanical Thrombectomy (PMT)
- •Inferior Vena Cava (IVC) Filter Placement
- •Preoperative Workup (Mandatory)
- Cardiac echo (if PE suspected): ¥560 ($78) - Coagulation panel + liver/kidney function: ¥310 ($43)
Special/Complex Condition Management
- •Cancer-Associated DVT: LMWH (e.g., dalteparin) preferred; monthly cost ¥2,400–¥3,600 ($334–$500)
- •Pregnancy-Related DVT: LMWH only; monitoring every 2 weeks (anti-Xa × 4): ¥720 ($100)
- •Post-Thrombotic Syndrome (PTS): Extended compression + pentoxifylline (¥420/month, $58) + endovascular stenting (¥32,000–¥49,000, $4,450–$6,810)
Quick Selection Guide
- •<60 years, no comorbidities, moderate DVT: DOAC (rivaroxaban) + stockings — Total Month 1: $223–$312
- •≥75 years, CKD Stage 3, high bleed risk: LMWH + renal-dose adjustment — Total Month 1: $110–$155
- •Acute limb-threatening DVT (<72 hr): PMT + IVC filter — Total procedural cost: $7,030–$12,160
- •Metastatic cancer + recurrent DVT: Long-term dalteparin — Annual cost: $4,010–$6,000
- •Budget-constrained outpatient (rural referral): Warfarin + INR monitoring (¥80/test, $11) — Monthly total: $45–$65, but requires strict adherence and weekly labs initially.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Deep Vein Thrombosis Medical Vacation Packages
Curated transparent all-inclusive packages combining Deep Vein Thrombosis treatment with China top medical destinations:
